年別の研究成果
年別の研究成果
検索結果
-
2021
Immune-checkpoint kinetics for T cells in anti-MDA5 positive interstitial lung disease
Suzuki, K., Yanagihara, T., Matsumoto, K., Chong, S. G., Ando, H., Ide, M., Arimura-Omori, M., Hata, K. & Hamada, N., 1月 1 2021, In: Rheumatology (United Kingdom). 60, 1, p. E14-E16研究成果: ジャーナルへの寄稿 › レター › 査読
Open Access1 被引用数 (Scopus) -
2018
Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer
Otsubo, K., Seki, N., Nakanishi, Y. & Okamoto, I., 3月 1 2018, In: Annals of Oncology. 29, 3, p. 780-781 2 p.研究成果: ジャーナルへの寄稿 › レター › 査読
4 被引用数 (Scopus) -
Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma
Yanagihara, T., Ikematsu, Y., Kato, K., Yonekawa, A., Ideishi, S., Tochigi, T., Sugio, T., Miyawaki, K., Tanaka, K., Harada, E., Hamada, N. & Nakanishi, Y., 2月 1 2018, In: Annals of Hematology. 97, 2, p. 359-360 2 p.研究成果: ジャーナルへの寄稿 › レター › 査読
6 被引用数 (Scopus) -
2017
Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1
Ikematsu, Y., Yoneshima, Y., Ijichi, K., Tanaka, K., Harada, T., Oda, Y., Nakanishi, Y. & Okamoto, I., 10月 2017, In: Lung Cancer. 112, p. 230-231 2 p.研究成果: ジャーナルへの寄稿 › レター › 査読
22 被引用数 (Scopus) -
Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease
Imamura, Y., Kawayama, T., Kinoshita, T., Sakazaki, Y., Yoshida, M., Takahashi, K., Fujii, K., Ando, M., Hoshino, T., Iwanaga, T., Kohrogi, H., Nakanishi, Y., Mukae, H., Watanabe, K., Hayashi, S., Kadota, J., Ii, T., Inoue, H., Tochigi, T., Fujita, J., & 1 others, 7月 2017, In: Allergology International. 66, 3, p. 482-484 3 p.研究成果: ジャーナルへの寄稿 › レター › 査読
10 被引用数 (Scopus) -
Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer
Ogata, H., Yamamoto, Y., Harada, T., Nakanishi, Y., Okamoto, I., Iwama, E., Iwama, E., Kato, K. & Oda, Y., 5月 2017, In: Journal of Thoracic Oncology. 12, 5, p. e46-e47研究成果: ジャーナルへの寄稿 › レター › 査読
Open Access5 被引用数 (Scopus) -
Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment
Yanagihara, T., Tanaka, K., ota, K., Kashiwagi, E., takeuchi, A., Tatsugami, K., Eto, M., Nakanishi, Y. & Okamoto, I., 8月 1 2017, In: Annals of Oncology. 28, 8, p. 2038-2039 2 p.研究成果: ジャーナルへの寄稿 › レター › 査読
11 被引用数 (Scopus) -
Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab
Otsubo, K., Nakatomi, K., Furukawa, R., Ashida, K., Yoneshima, Y., Nakanishi, Y. & Okamoto, I., 12月 1 2017, In: Annals of Oncology. 28, 12, p. 3106-3107 2 p.研究成果: ジャーナルへの寄稿 › レター › 査読
12 被引用数 (Scopus)